Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04208139 · ClinicalTrials.gov registry record
A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center Follow up
A clinical trial of Recurrent Pulmonary Embolism (Disorder), sponsored by NC Heart and Vascular Research.
- Completed
- Registry status
- 11
- Enrollment target
- 1
- Study location
NCT04208139 is a study of Recurrent Pulmonary Embolism (Disorder) that has completed, run by NC Heart and Vascular Research. The registered enrollment target is 11 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04208139, a study of Recurrent Pulmonary Embolism (Disorder), has completed, sponsored by NC Heart and Vascular Research.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
IVUS Evaluation of the Bioabsorbable Sentry IVC Filter 3-5 Years Post Deployment Follow up
Conditions Studied
Interventions
- DIAGNOSTIC_TEST IVUS
Study Locations (1)
North Carolina
- NC Heart and Vascular Research, LLC - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-03-14 |
| Est. Completion | 2020-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04208139
The ClinicalTrials.gov registry entry for NCT04208139 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NC Heart and Vascular Research, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Recurrent Pulmonary Embolism (Disorder) appearing as the primary indexed condition, and to 1 intervention - of which IVUS is the first listed.
NCT04208139 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT04208139 about?
NCT04208139 is a clinical study titled "A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center Follow up". IVUS Evaluation of the Bioabsorbable Sentry IVC Filter 3-5 Years Post Deployment Follow up
What is the current status of trial NCT04208139?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2020-03-14. Estimated completion is 2020-10-01.
What conditions does trial NCT04208139 study?
This clinical trial studies the following conditions: Recurrent Pulmonary Embolism (Disorder).
What interventions are being tested in trial NCT04208139?
The interventions under investigation include: IVUS (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04208139?
This trial is sponsored by NC Heart and Vascular Research, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04208139 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.